Deferiprone is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Taro Pharmaceuticals U.s.a., Inc.. The primary component is Deferiprone.
| Product ID | 51672-4196_4028eb31-5ba4-4626-9f1c-32e913896561 |
| NDC | 51672-4196 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Deferiprone |
| Generic Name | Deferiprone |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-02-08 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA208800 |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Substance Name | DEFERIPRONE |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Iron Chelating Activity [MoA],Iron Chelator [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2019-02-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA208800 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-02-08 |
| Ingredient | Strength |
|---|---|
| DEFERIPRONE | 500 mg/1 |
| SPL SET ID: | 5af1643d-4c6e-4668-ae9b-1046f0ad6d8a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-0576 | Deferiprone | Deferiprone |
| 0054-0711 | Deferiprone | Deferiprone |
| 51672-4196 | Deferiprone | Deferiprone |
| 10122-100 | FERRIPROX | deferiprone |
| 10122-101 | FERRIPROX | deferiprone |
| 10122-103 | FERRIPROX | DEFERIPRONE |
| 10122-104 | FERRIPROX | deferiprone |
| 52609-0006 | FERRIPROX | deferiprone |
| 52609-0007 | FERRIPROX | deferiprone |
| 52609-4502 | FERRIPROX | deferiprone |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DEFERIPRONE 97303966 not registered Live/Pending |
Beer, Kenneth 2022-03-09 |